ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 3212

Characterizing the Effects of the G-CSF-R Coding rs13377964 SNP Located within Murine Lupus Susceptibility Locus Sle2c2

Ramya Sivakumar1 and Laurence Morel2, 1Pathology, University of Florida, Gainesville, FL, 2Pathology, Immunology, and Laboratory Medicine, University of Florida, Gainesville, FL

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: dendritic cells and neutrophils, SLE

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, November 10, 2015

Title: Systemic Lupus Erythematosus - Animal Models

Session Type: ACR Concurrent Abstract Session

Session Time: 4:30PM-6:00PM

Background/Purpose:

The genetic analysis of the lupus prone NZM2410 mouse has identified a suppressor locus, Sle2c2, which confers resistance to both spontaneous and chronic graft-vs.-host disease (cGVHD) induced lupus. We hypothesized that a non-synonymous polymorphism in the granulocyte colony stimulating factor (G-CSF) receptor 3 (Csf3r) gene in Sle2c2 is responsible for providing protection. G-CSF acts as a pleiotropic growth factor and mediates its biological functions including granulopoiesis by binding specifically to G-CSF-R. Exogenous G-CSF restored cGVHD susceptibility in Sle2c2, suggesting that the Csf3r rs13377964 coding SNP results in a loss-of-function in signaling modulating the expression of targets in myeloid cells expressing G-CSF-R, including neutrophils and dendritic cells, and thus mediating lupus resistance.

Methods:

We investigated the functional differences between the wild type B6 and congenic Sle2c2 alleles of Csf3r transduced in the murine Csf3r-negative myeloblast- like 32d.cl3 cell line with a lentiviral vector. G-CSF-R signaling was measured using phospho-flow staining and gene expression assays in transduced 32d.cl3 cells stimulated with mouse G-CSF. Furthermore, the assays were repeated using primary bone-marrow derived dendritic cells, splenocytes and peripheral blood leukocytes of B6 and congenic B6.Sle2c2mice. In addition, the progression and activation of G-CSF-R expressing myeloid cells throughout the entire course of cGVHD was compared between B6 and congenic mice by flow cytometry.

Results:

32d.cl3 cells expressing the Sle2c2 allele of G-CSF-R showed a reduced expression of Jak and Src targets in response to G-CSF with both phospho-flow and gene expression assays. The Sle2c2 allele of G-CSF-R induced a reduced phosphorylation of STAT3, ERK and p38 and lowered the expression of genes such as SOCS3, cFOS, Fcgr3, IRF1 compared to B6 allele. The effects of phospho signaling associated with Jak-STAT and ERK pathways were recapitulated with ex-vivo experiments using primary BM derived DCs as well as total splenic and blood neutrophils. Differences in frequency of G-CSF-R positive neutrophils and splenic dendritic cell subsets as well as levels of G-CSF-R expression during the course of cGVHD further suggest the functional relevance of the G-CSF-R SNP in lupus.

Conclusion: Our results show that the coding rs13377964 SNP affects G-CSFR signaling, supporting the hypothesis that it could confer resistance to lupus. The defective signaling observed downstream of G-CSF-R primarily within the Jak and Src pathways in both primary cells and cell lines transduced with Csf3r alleles suggest the functional relevance of the polymorphism. Both Jak and Src kinase pathways are involved in differentiation, proliferation and survival of myeloid progenitor cells and activation of neutrophils. Future experiments aimed at elucidating the differences in functions of these pathways using cell lines and myeloid cells such as neutrophils and dendritic cells will enhance our understanding of the GCSFR axis in lupus pathogenesis.


Disclosure: R. Sivakumar, None; L. Morel, None.

To cite this abstract in AMA style:

Sivakumar R, Morel L. Characterizing the Effects of the G-CSF-R Coding rs13377964 SNP Located within Murine Lupus Susceptibility Locus Sle2c2 [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/characterizing-the-effects-of-the-g-csf-r-coding-rs13377964-snp-located-within-murine-lupus-susceptibility-locus-sle2c2/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/characterizing-the-effects-of-the-g-csf-r-coding-rs13377964-snp-located-within-murine-lupus-susceptibility-locus-sle2c2/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology